The Malignant Germ Cell International Consortium (MaGIC) brings together the world’s leading experts in germ cell tumors (GCTs), from across the spectrum of cancer research, with the shared goal of developing more effective treatments for GCTs through scientific inquiry.
Lindsay Frazier, MD, Pediatric Hematology/Oncology, Dana-Farber Cancer Institute, Harvard Medical School, discusses the Malignant Germ Cell International Consortium (MaGIC).
Our collaboration across a wide range of disciplines—clinical trialists, basic scientists, bioinformaticists, pathologists, statisticians, surgeons, epidemiologists—is allowing us to accelerate the pace of discovery and the promise of change.
Since its inception in 2009, MaGIC has grown to include clinical and basic scientists from more than 40 institutions in 11 countries. Sharing experience, expertise, and culture continues to create new opportunities for advancement in the field of GCT research.